Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches (original) (raw)
Levi-Montalcini, R. The nerve growth factor: thirty-five years later. EMBO J.6, 1145–1154 (1987). ArticleCAS Google Scholar
Barde, Y.-A. The nerve growth factor family. Prog. Growth Factor Res.2, 237–348 (1990). ArticleCAS Google Scholar
Bibel, M. & Barde, Y.-A. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev.14, 2919–2937 (2000). ArticleCAS Google Scholar
Kaplan, D.R. & Miller, F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol.10, 381–391 (2000). ArticleCAS Google Scholar
Hempstead, B.L. The many faces of p75 (NTR). Curr. Opin. Neurobiol.12, 260–267 (2002). ArticleCAS Google Scholar
Donovan, M.J. et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development127, 4531–4540 (2000). CAS Google Scholar
Kerschensteiner, M., Stadelmann, C., Dechant, G., Wekerle, H. & Hohlfeld, R. Neurotrophic cross-talk between the nervous and immune systems: implications for inflammatory and degenerative neurological diseases. Ann. Neurol. (in press).
Hefti, F. & Weiner, W.J. Nerve growth factor and Alzheimer's disease. Ann. Neurol.20, 275–281 (1986). ArticleCAS Google Scholar
Fisher, W. et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature329, 65–68 (1987). Article Google Scholar
Lindsay, R.M., Wiegand, S.J., Altar, C.A. & DiStefano, P.S. Neurotrophic factors: from molecule to man. Trends Neurosci.17, 182–190 (1994). ArticleCAS Google Scholar
Sendtner, M., Holtmann, B. & Hughes, R.A. The response of motoneurons to neurotrophins. Neurochem. Res.21, 831–841 (1996). ArticleCAS Google Scholar
Sendtner, M. et al. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature358, 502–504 (1992). ArticleCAS Google Scholar
Mitsumoto, H. et al. Arrests of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science265, 1107–1110 (1994). ArticleCAS Google Scholar
Dittrich, F. et al. Pharmacokinetics of intrathecally apllied BDNF and effects on spinal motoneurons. Exp. Neurol.141, 225–239 (1996). ArticleCAS Google Scholar
Knusel, B. et al. Ligand-induced down-regulation of trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons. Neuroscience78, 851–862 (1997). ArticleCAS Google Scholar
Thoenen, H. in Axonal Regeneration in the Central Nervous System (eds. Ingoglia, N.A. & Murray, M.) 675–697 (Marcel Dekker, New York and Basel, 2000). Google Scholar
McAllister, A.K., Katz, L.C. & Lo, D.C. Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci.22, 295–318 (1999). ArticleCAS Google Scholar
Zhang, L.I. & Poo, M.-M. Electrical activity and development of neural circuits. Nat. Neurosci.4 (Suppl), 1207–1214 (2001). ArticleCAS Google Scholar
Berardi, N., Pizzorusso, T. & Maffei, L. Critical periods during sensory development. Curr. Opin. Neurobiol.10, 138–145 (2000). ArticleCAS Google Scholar
Binder, D.K., Croll, S.D., Gall, C.M. & Scharfman, H.E. BDNF and epilepsy: too much of a good thing? Trends Neurosci.24, 47–53 (2001). ArticleCAS Google Scholar
Lowenstein, P.R. & Enquist, L.W. Protocols for Gene Transfer in Neuroscience (Wiley, Chichester, UK, 1996). Google Scholar
Gravel, C., Gotz, R., Lorrain, A. & Sendtner, M. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat. Med.3, 765–770 (1997). ArticleCAS Google Scholar
Kordower, J.H. et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science290, 767–773 (2000). ArticleCAS Google Scholar
Rossi, F.M.V. & Blau, H.M. Recent advances in inducible gene expression systems. Curr. Opin. Biotechnol.9, 451–456 (1998). ArticleCAS Google Scholar
Mansuy, I.M. & Bujard, H. Tetracycline-regulated gene expression in the brain. Curr. Opin. Neurobiol.10, 593–596 (2000). ArticleCAS Google Scholar
Huang, Z.J. et al. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell98, 739–755 (1999). ArticleCAS Google Scholar
Cotman, C.W. & Berchtold, N.C. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci.25, 295–301 (2002). ArticleCAS Google Scholar
Carro, E., Nuñez, A., Busiguina, S. & Torres-Aleman, I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J. Neurosci.20, 2926–2933 (2000). ArticleCAS Google Scholar
Carro, E., Trejo, J.L., Busiguina, S. & Torres-Aleman, I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J. Neurosci.21, 5678–5684 (2001). ArticleCAS Google Scholar
Baekelandt, V., De Strooper, B., Nuttin, B. & Debyser, Z. Gene therapeutic strategies for neurodegenerative diseases. Curr. Opin. Mol. Ther.2, 540–554 (2000). CASPubMed Google Scholar
Vigna, E. et al. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Therapy5, 252–261 (2002). ArticleCAS Google Scholar
Cheng, L., Saphieha, P., Kittlerova, P., Hauswirth, W.W. & Di Polo, A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J. Neurosci.22, 3977–3986 (2002). ArticleCAS Google Scholar
Lee, F.S., Rajagopal, R. & Chao, M.V. Distinctive features of Trk neurotrophins receptor transactivation by G protein-coupled receptors. Cytokine Growth Factor Rev.13, 11–17 (2002). ArticleCAS Google Scholar
Hefti, F. Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol.37, 239–267 (1997). ArticleCAS Google Scholar
Swain, C., Harper, S., Polack, S., Smith, R. & Hefti, F. in Handbook of Experimental Pharmacology (ed. Hefti, F.) 281–309 (Springer Verlag, Heidelberg/Berlin, 1999). Google Scholar
Venters, H.D., Dantzer, R. & Kelley, K.W. A new concept in neurodegeneration: TNF-alpha is a silencer of survival signals. Trends Neurosci.23, 175–180 (2000). ArticleCAS Google Scholar
The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. Clin. Neuropharmacol.18, 515–532 (1995).
Miller, R.G. et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann. Neurol.39, 256–260 (1996). ArticleCAS Google Scholar
ALS CNTF Treatment Study group (ACTS). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology46, 1244–1249 (1996).
Aebischer, P. et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med.2, 696–699 (1996). ArticleCAS Google Scholar
Penn, R.D. Kroin, J.S., York, M.M. & Cedarbaum, J.M. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery40, 94–99 (1997). CASPubMed Google Scholar
Bachoud-Levi, A.C. et al. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum. Gene Ther.11, 1723–1729 (2000). ArticleCAS Google Scholar
Ericsdotter Jönhagen, M. et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dementia Geriatr. Cogn. Disord.9, 246–257 (1998). Article Google Scholar
Apfel, S.C. et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology51, 695–702 (1998). ArticleCAS Google Scholar
Apfel, S.C. et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA284, 2215–2221 (2000). ArticleCAS Google Scholar
McArthur, J.C. et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology54, 1080–1088 (2000). ArticleCAS Google Scholar
Schifitto, G. et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology57, 1313–1316 (2001). ArticleCAS Google Scholar
A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III). Neurology52, 1427–1433 (1999).
Ochs, G. et al. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord.1, 201–206 (2000). ArticleCAS Google Scholar
Wellmer, A., Misra, V.P., Sharief, M.K., Kopelman, P.G. & Anand, P. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy. J. Peripher. Nerv. Syst.6, 204–210 (2001). ArticleCAS Google Scholar
Chaudhry, V. et al. Tolerability of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy subjects. Muscle Nerve23, 189–192 (2000). ArticleCAS Google Scholar
Lai, E.C. et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology49, 1621–1630 (1997). ArticleCAS Google Scholar
Borasio, G.D. et al. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology51, 583–586 (1998). ArticleCAS Google Scholar